American Association for the Advancement of Science, Science Translational Medicine, 573(12), 2020
DOI: 10.1126/scitranslmed.aaz7423
Full text: Unavailable
At 96 weeks after unilateral intravitreal injection of rAAV2/2- ND4 , vision improved in both eyes in 78% of subjects affected with LHON.